Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation—The POWER Survey
Figure 2
Chart-based estimates of SCORE risk distributions at baseline and at the end of observation, overall and by sex. Estimates based on ,718 at baseline and at 6 months. Low risk <1%; moderate risk 1–4%; high risk 5–9%; very high risk ≥10%.
